Quantification of Atherosclerosis in Mice

Monica Centa1, Daniel F J Ketelhuth2, Stephen Malin1

  • 1Cardiovascular Medicine Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital.

Insights

This study presents a standardized protocol for evaluating atherosclerosis in mouse models. This method enhances reproducibility and reduces variability in experimental atherosclerosis research.

Area of Science:

  • Cardiovascular research
  • Immunology
  • Pathology

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Atherosclerosis, a primary driver of CVD, involves chronic inflammation and lipid accumulation.
  • Previous research in mouse models has identified key roles for cholesterol and inflammation.

Purpose of the Study:

  • To provide a standardized protocol for evaluating atherosclerosis in mouse models.
  • To enable comprehensive lesion analysis at multiple arterial sites within a single animal.
  • To improve reproducibility and reduce variability in experimental atherosclerosis studies.

Main Methods:

  • Detailed technical description for evaluating atherosclerotic lesions.
  • Focuses on lesion quantification in the aortic root, aortic arch, and brachiocephalic artery.
  • Designed for efficient use of limited biological material, such as in genetically modified mouse studies.

Main Results:

  • The protocol allows for simultaneous assessment of atherosclerosis at critical vascular sites.
  • Standardization of lesion analysis minimizes experimental variability.
  • Increases the reproducibility of findings in atherosclerosis research.

Conclusions:

  • This protocol offers a valuable tool for researchers studying atherosclerosis pathogenesis.
  • It is particularly useful for characterizing atherosclerosis in genetically modified mouse models.
  • Standardized analysis is crucial for advancing our understanding and treatment of atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
343
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
976
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
485
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
394
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.0K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.1K